Background Diabetes mellitus has many complications; hypoglycemia is one of them that is associated with severe signs and symptoms such as anxiety, psychosocial problems, and poor metabolic control. Objective This study aimed to investigate the factors affecting hypoglycemia fear in patients with type 2 diabetes. Methods The present descriptive-analytic study was conducted on 360 patients with type 2 diabetes referred to Velayat Hospital in Qazvin City, Iran, in 2017. The eligible samples were recruited through a convenience sampling method. The data collection instruments were a demographic checklist and the Hypoglycemia Fear Survey-II scale. The collected data were analyzed using descriptive tests, t-test, oneway ANOVA, the Pearson correlation, and regression analysis. Findings The Mean±SD age of the patients was 58.5±14.3 years, and the majority of them were women (65.3%). The Mean±SD score of hypoglycemia fear was 22.07±8.6 which was significant in terms of gender (P=0.002), type of treatment (P<0.001), employment (P=0.05), and educational status (P=0.05). The results of single-variable regression showed that the type of treatment (P<0.001), long-term complications (P=0.002), and gender (P=0.002) were associated with hypoglycemia fear. Also, the results of simultaneous regression showed that the type of treatment was associated with hypoglycemia fear (P<0.001). Conclusion The results of this study showed that the type of treatment was the most effective factor in hypoglycemia fear. Using insulin to treat diabetes strongly affect the hypoglycemia fear; therefore, it is possible to reduce the hypoglycemia fear by appropriate patients' instructions on how to inject and monitor insulin.
Introduction
iabetes mellitus is currently one of the most prevalent metabolic disorders in the world, affecting 1 out of 11 people [2, 3] . The goal of diabetes treatment is to lower blood sugar level and prevent its complications [7, 8] . Diabetes has many complications; one of its major complications is hypoglycemia [9] . The risk of hypoglycemia, which is life-threatening, increases when blood glucose reaches normal levels [10] . Therefore, one of the main goals of diabetes treatment is the prevention of hypoglycemia [11] . The term "fear of hypoglycemia" is used to indicate severe symptoms such as anxiety in diabetic patients and their families. It causes concern about blood glucose drop and avoidance behaviors such as excessive glucose monitoring, reduced insulin consumption, and overtreatment of hypoglycemia [15, 16] .
Fear of hypoglycemia requires more attention and control to understand the behaviors of diabetics [13] . Although this topic is widespread in other countries than in Iran, the limited local information related to the fear of hypoglycemia in the Iranian population urged the researchers to address this new issue. Hence, this study aims to investigate the factors affecting the fear of hypoglycemia in patients with type 2 diabetes (T2D).
Materials and Methods
This is a descriptive-analytical study conducted in 2017 on 360 patients with T2D referred to the clinics and departments of Velayat Hospital in Qazvin City, Iran who were recruited using convenience sampling technique and based on inclusion criteria being 18-65 years old and having T2D diagnosed by the endocrinologist. The exclusion criteria were being pregnant, having T1D, and suffering from acute psychological problems or specific illness (according to the physician) in the past 6 weeks.
The data collection tool was a two-part questionnaire. The first part surveys demographic characteristics (age, gender, marital status, education, occupation, duration of disease, type of treatment, and underlying illness). The second part was the hypoglycemia fear survey-worry subscale (HFS-W). It has 18 items rated on a 5-point Likert scale ranging from 0 (never) to 4 (always) measuring the degree of hypoglycemia fear in the past 6 months. The total scores range from 0-72.
The collected data were analyzed in SPSS V. 24 . The independent t-test and one-way ANOVA were used to study hypoglycemia fear based on demographic factors, and multiple linear regression for examining the effect of other factors. The significance level was set as (P<0.05).
Results
The majority of participants were female (n=235, 65.3%) and under treatment with oral anti-diabetic pills (n=153, 42.5%). Most of them (n=311, 86.5%) had complications of diabetes. Their mean total score of hypoglycemia fear was 22.07±8.6. There was a significant correlation between gender and fear of hypoglycemia (P=0.002), and hypoglycemia fear score was higher in females (23.43±10.9) than in males (19.48±13.01). Moreover, there was a significant relationship between educational levels and fear of hypoglycemia (P=0.05), and the lowest score was for those who had a university education (17.55±13.46). There was a significant correlation between occupation and fear of hypoglycemia (P=0.052), and those who were employed had the lowest fear level (15.47±9.63). The type of treatment was another variable associated with fear of hypoglycemia (P <0.001), and those treated with oral anti-diabetes pills had the least fear (18.92±11.93).
In the regression analysis of the factors influencing hypoglycemia fear among groups, the results showed that type of treatment, long-term complications, and gender had significant effects on hypoglycemia fear. By changing the patient's treatment method, hypoglycemia fear score varies, such that its score in patients treated with insulin was (0.27)units higher than in those treated with oral medications (P<0.001, β=0.27). Moreover, its score in patients treated with both insulin and oral medications was (0.18) units higher than that in those treated with oral medications only (P<0.001, β=0.18).
Conclusion
The results of this study showed that insulin therapy, education, occupation, and gender are factors influencing hypoglycemia fear in patients with T2D. This finding is consistent with the results of Martyn-Nemeth et al. Momeni et al. and Hajos et al. studies [10, 13, 23] . Therefore, it is recommended that all diabetic patients, especially insulindependent patients, be examined for fear of hypoglycemia, and interventional studies, be conducted to manage these fears. Moreover, due to the higher prevalence of hypoglycemia fear in insulin-treated patients, it is recommended that education about insulin function and how to manage occupational performance and activities be given to patients before starting insulin treatment.
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